Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has said he wants to study the safety of mifepristone, one of two drugs used in medication abortion.
open to restrictions on the pill.
“President Trump has asked me to study the safety of mifepristone,” Kennedy said during a confirmation hearing. “He has not yet taken a stand on how to regulate it. Whatever he does, I will implement those policies.”
Health policy experts do not think that Kennedy will try to remove the drug from the market straight away. Instead, they think he might direct agencies within HHS to change who can take mifepristone and how it can be administered.
Right now, mifepristone can be prescribed online and sent through the mail and is approved to end a pregnancy in the first 10 weeks of gestation.
Health experts who spoke to The Hill agreed the easiest way Kennedy could change access to the drug is through trying to alter its Risk Evaluation and Mitigation Strategies (REMS). REMS are regulations added to some medications with safety concerns.
REMS changes typically take time, but there’s concern that the Trump administration could try to speed up the process by issuing an executive order based on a study claiming mifepristone is dangerous for public consumption and applying pressure to the FDA to restore previous restrictions.
What’s a REMS: The Food and Drug Administration (FDA) is responsible for protecting public health by ensuring medications are safe and effective.
One of the ways the agency does this is by implementing REMS.
REMS can include some interventions to ensure the safe use of a drug, like requiring patients to undergo certain tests before they can be prescribed a medication or requiring that it be administered in clinic.
Mifepristone has had a REMS since it was first approved by the FDA in 2000, and it’s been modified multiple times over the years, most recently in 2023 when the FDA dropped an in-person dispensing requirement for the drug.
Changing the REMS for a drug is not normally a quick process. Often, it is the drug manufacturer that requests changes to these rules, although the FDA can also request changes. Typically, the agency needs to work with the manufacturer to roll out those modifications.
Essential Reads
Wyden, Sanders: Federal layoffs threaten organ transplant system modernization
Full StoryThe editorial board of the New York Post is urging Health and Human Services Secretary Robert F. Kennedy Jr. to clarify that the measles vaccine is safe amid a deadly outbreak in Texas. “Go to Texas, Mr. Secretary, and preach the truth as only a convert can: This vaccine is safe, and getting children jabbed is an act of love,” the Post wrote to Kennedy. “That’s why all your children are …
The Hill event
Local and state headlines on health care:
New York health officials urge measles vaccination amid rise in cases (Gothamist) Louisiana officials urge measles vaccination after outbreak in Texas killed a child (NOLA.com) Health officials confirm third Michigan child dies from influenza this season (CBS)What Others are Reading
Trump cuts off talk of Canada annex alongside UK’s Starmer: ‘That’s enough’
Trump on calling Zelensky a dictator: ‘Did I say that?’
What People Think
You're all caught up. See you tomorrow!
CloseThank you for signing up!
here
The latest in politics and policy. Direct to your inbox. Sign up for the Health Care newsletter Subscribe Read More Details
Finally We wish PressBee provided you with enough information of ( Abortion medication faces RFK Jr. scrutiny )
Also on site :
- Country 'MVP' Refunds Entire Audience Mid-Concert and Fans 'Cannot Believe He Did That'
- With Property Seized and Federal Funding Uncertain, Montana Asbestos Clinic Fights for Its Life
- Trump fija nuevo plazo de negociación de dos semanas y desencadena esfuerzo urgente por reanudar las conversaciones con Irán